The reason for this phenomenon may be that although peripheral insulin injections are the classical way to treat T2D, they may induce hypoglycemia in stroke patients with only an insulin-resistant state that has not yet developed T2D, and this hypoglycemia can cause secondary brain damage, and peripheral insulin injections may be ineffective due to impaired insulin transport by BBB. The gene discussed is INS; the disease is Stroke.